Cart is empty
A unique, patented strain combination probiotic. entiro™ contains a 50/50 split of Lactobacillus plantarum 423 & Enterococcus mundtii ST4SA
entiro™ was developed through the award-winning research of Professor Leon Dicks from the University of Stellenbosch. It is manufactured in the world class facilities of Danish probiotic manufacturing specialists, Bifodan.
Balancing the good and the bad:
The human body plays host to a variety of micro-organisms. The largest concentration of these organisms is found in the gastrointestinal tract. In a healthy gut, micro-organisms (gut flora), both good and bad, live in a natural balance, where they play an important role in maintaining digestive system- and overall health.
When the gut flora balance is disturbed, susceptibility to disease increases. Digestive disturbances including bloating, flatulence, and diarrhoea may result. Gut flora imbalance is also considered to play an important role in inflammatory disease such as irritable bowel syndrome.
Probiotics play an important role in restoring and maintaining gut flora balance.
Factors which may contribute to gut flora imbalance include:
There are approximately 10 times more micro-organisms than human cells in your body
If spread out, the microbiota (micro-organisms) in your gut is enough to cover a tennis field
Your body plays host to more than 500 different types of bacteria
All babies are born sterile, without any micro-organisms, their microbiota only established in the first few months of life
Myths vs Facts:1-4
Myth: Yoghurt is an effective probiotic
A big myth. The minimum effective dose of probiotics required is 100 million colony forming units (CFU’s). Unless one consumes approximately 40 litres of yoghurt daily, most yoghurt products do not contain a sufficient amount of CFU’s to be effective.
Myth: More strains are better
Not necessarily. What’s important is not so much the number of different strains, but the number of viable cells (CFU’s) in the probiotic formulation. In the GIT, the various strains will compete with each other for the limited number of available binding sites.
Myth: Probiotics are for use with antibiotic therapy
That’s about half right, as probiotics are not limited to acute use such as during antibiotic therapy. Probiotics have been shown to be beneficial in a wide variety of conditions including irritable bowel syndrome and other digestive disturbances, traveller’s diarrhoea and gynaecological health.
What makes entiro™ different?
Unlike its competitors: entiro™ LINES, BINDS and PROTECTS the Entire Gut, maintaining and balancing intestinal flora.
L. plantarum adheres predominantly to the small intestine due to the prevailing acidic and aerobic environment. E. mundtii prefers the more alkaline & anaerobic conditions of the large intestine. This results in a complete lining of the gastrointestinal tract.
Both L. plantarum and E. mundtii contain genes encoding adhesion proteins and can therefore facilitate stronger binding to the mucus and epithelial layers of the ENTIRE gut. Adhesion prevents cells from being eliminated by peristalsis. It also prevents pathogens from binding to adhesion sites by a process of competitive exclusion.
A rather unique property entiro™ exhibits is the CONTINUOUS PRODUCTION OF POWERFUL ANTIMICROBIAL PEPTIDES that kill intestinal pathogens. This is achieved through pore formation in the pathogen, causing cellular contents to leak out, effectively killing it.
entiro™ is available in packs of 10 (for acute use such as during antibiotic therapy) and 30’s (for daily use). entiro™ capsules are suitable for vegetarians